Café

© 2026 Longbridge｜Terms of Service Privacy Policy

BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

Unusual Whales

Mar 11, 2026 at 12:47 AM

Stringent board oversight is bringing a subsidiary in line with a structured approach to capital allocation and strategic evaluation.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

Apr 20, 2026 at 06:34 PMEli Lilly Announces $7 Billion Acquisition of Kelonia: Pioneering the 'In Vivo CAR-T' Frontier and Leading Gene Therapy …
Apr 16, 2026 at 11:12 AMUS Stocks Hit New Highs, Retail Investors Miss Out en masse: Tom Lee Says Next Rally Will Be Led by Them
Apr 13, 2026 at 01:07 AMU.S. Stocks Face a "Final Battle" as Hormuz Outcome Decides the Game: The Rash Never Win, the Patient Prevail
Apr 7, 2026 at 10:32 PMReminder: Key events to watch intraday (all times Beijing Time)

Related Stocks

BioNexus Gene Lab

USBGLC

iShares Genomics Immunology and Healthcare ETF

USIDNA

Invesco Biotechnology & Genome ETF

USPBE

LongbridgeAI